Tzu Phang
Concepts (329)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Software | 5 | 2013 | 536 | 0.480 |
Why?
| Gene Expression Profiling | 15 | 2014 | 1521 | 0.480 |
Why?
| Receptors, Glucocorticoid | 4 | 2017 | 130 | 0.470 |
Why?
| Databases, Genetic | 3 | 2009 | 206 | 0.400 |
Why?
| Gene Expression Regulation | 9 | 2017 | 2321 | 0.390 |
Why?
| Mammary Glands, Animal | 3 | 2006 | 116 | 0.320 |
Why?
| Chorionic Gonadotropin | 5 | 2000 | 78 | 0.310 |
Why?
| Alternative Splicing | 1 | 2009 | 188 | 0.300 |
Why?
| Receptors, LH | 4 | 2000 | 9 | 0.290 |
Why?
| Nuclear Proteins | 3 | 2017 | 592 | 0.280 |
Why?
| Kruppel-Like Transcription Factors | 2 | 2017 | 61 | 0.260 |
Why?
| Oligonucleotide Array Sequence Analysis | 12 | 2014 | 743 | 0.260 |
Why?
| Computational Biology | 4 | 2013 | 530 | 0.230 |
Why?
| Face | 3 | 2017 | 168 | 0.230 |
Why?
| Lymphoma, Non-Hodgkin | 1 | 2022 | 71 | 0.190 |
Why?
| Dog Diseases | 2 | 2012 | 41 | 0.180 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 229 | 0.180 |
Why?
| Precision Medicine | 1 | 2024 | 338 | 0.180 |
Why?
| Precancerous Conditions | 1 | 2021 | 158 | 0.170 |
Why?
| Hemangiosarcoma | 2 | 2010 | 18 | 0.170 |
Why?
| Hermanski-Pudlak Syndrome | 1 | 2019 | 2 | 0.170 |
Why?
| Respiratory System | 2 | 2017 | 137 | 0.160 |
Why?
| Guanine Nucleotide Exchange Factors | 1 | 2019 | 55 | 0.160 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2017 | 799 | 0.160 |
Why?
| Systems Biology | 2 | 2017 | 56 | 0.160 |
Why?
| Pulmonary Alveoli | 2 | 2012 | 372 | 0.160 |
Why?
| Gene Expression Regulation, Neoplastic | 4 | 2012 | 1147 | 0.160 |
Why?
| Database Management Systems | 2 | 2009 | 48 | 0.160 |
Why?
| Phospholipase C delta | 1 | 2017 | 3 | 0.150 |
Why?
| Proteins | 3 | 2000 | 912 | 0.140 |
Why?
| Airway Remodeling | 1 | 2017 | 57 | 0.140 |
Why?
| Maxillofacial Development | 1 | 2017 | 18 | 0.140 |
Why?
| Ectoderm | 1 | 2017 | 43 | 0.140 |
Why?
| Muscle, Smooth | 1 | 2017 | 144 | 0.140 |
Why?
| Cluster Analysis | 4 | 2010 | 460 | 0.130 |
Why?
| Pulmonary Fibrosis | 1 | 2019 | 322 | 0.130 |
Why?
| Mesoderm | 1 | 2017 | 138 | 0.130 |
Why?
| Photoaffinity Labels | 3 | 2000 | 5 | 0.130 |
Why?
| DNA Copy Number Variations | 2 | 2021 | 158 | 0.130 |
Why?
| Transcription Factor RelA | 1 | 2016 | 83 | 0.130 |
Why?
| Saccharopine Dehydrogenases | 1 | 2015 | 3 | 0.130 |
Why?
| Proline Oxidase | 1 | 2015 | 5 | 0.130 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 319 | 0.130 |
Why?
| Chromatin Immunoprecipitation | 2 | 2017 | 129 | 0.120 |
Why?
| Gene Expression | 3 | 2016 | 1420 | 0.120 |
Why?
| Response Elements | 1 | 2015 | 83 | 0.120 |
Why?
| Dogs | 3 | 2012 | 334 | 0.120 |
Why?
| Fibroblast Growth Factor 8 | 1 | 2014 | 27 | 0.120 |
Why?
| DNA-Binding Proteins | 2 | 2014 | 1314 | 0.120 |
Why?
| Cleft Lip | 1 | 2014 | 32 | 0.120 |
Why?
| Lung Neoplasms | 2 | 2021 | 2199 | 0.120 |
Why?
| Transcription Factor AP-2 | 1 | 2014 | 81 | 0.120 |
Why?
| Cleft Palate | 1 | 2014 | 46 | 0.120 |
Why?
| Internet | 2 | 2009 | 596 | 0.120 |
Why?
| Lactation | 2 | 2006 | 151 | 0.110 |
Why?
| Transcription, Genetic | 3 | 2015 | 1316 | 0.110 |
Why?
| Gene Dosage | 1 | 2014 | 134 | 0.110 |
Why?
| Gene Regulatory Networks | 3 | 2013 | 228 | 0.110 |
Why?
| Cell Line | 6 | 2016 | 2639 | 0.110 |
Why?
| Epithelial Cells | 2 | 2016 | 955 | 0.110 |
Why?
| Mice | 12 | 2021 | 14916 | 0.110 |
Why?
| Membrane Proteins | 1 | 2019 | 1022 | 0.110 |
Why?
| Introns | 1 | 2014 | 227 | 0.110 |
Why?
| Antiporters | 2 | 2003 | 18 | 0.110 |
Why?
| Lymphoma, T-Cell | 1 | 2012 | 21 | 0.100 |
Why?
| Anti-Inflammatory Agents | 1 | 2016 | 450 | 0.100 |
Why?
| NF-kappa B | 2 | 2014 | 636 | 0.100 |
Why?
| Animals | 17 | 2021 | 31761 | 0.100 |
Why?
| Growth Hormone-Secreting Pituitary Adenoma | 1 | 2012 | 11 | 0.100 |
Why?
| Iodine Radioisotopes | 5 | 2000 | 126 | 0.100 |
Why?
| Transcriptome | 2 | 2017 | 727 | 0.100 |
Why?
| Lymphoma, B-Cell | 1 | 2012 | 86 | 0.100 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 386 | 0.090 |
Why?
| Immunity, Innate | 3 | 2012 | 723 | 0.090 |
Why?
| Genomics | 2 | 2024 | 639 | 0.090 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2016 | 928 | 0.090 |
Why?
| Databases, Nucleic Acid | 1 | 2010 | 32 | 0.090 |
Why?
| Comparative Genomic Hybridization | 1 | 2010 | 28 | 0.090 |
Why?
| Philadelphia Chromosome | 1 | 2010 | 15 | 0.090 |
Why?
| Humans | 28 | 2024 | 114756 | 0.090 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2012 | 139 | 0.090 |
Why?
| Influenza A virus | 1 | 2011 | 90 | 0.090 |
Why?
| Fusion Proteins, bcr-abl | 1 | 2010 | 61 | 0.090 |
Why?
| Adenoma | 1 | 2012 | 189 | 0.090 |
Why?
| Down-Regulation | 2 | 2010 | 596 | 0.090 |
Why?
| Dexamethasone | 3 | 2017 | 317 | 0.090 |
Why?
| NFATC Transcription Factors | 1 | 2010 | 78 | 0.090 |
Why?
| Reoviridae | 1 | 2010 | 35 | 0.090 |
Why?
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 95 | 0.080 |
Why?
| Encephalitis, Viral | 1 | 2010 | 39 | 0.080 |
Why?
| Algorithms | 2 | 2009 | 1468 | 0.080 |
Why?
| Reoviridae Infections | 1 | 2010 | 52 | 0.080 |
Why?
| Alcohol-Related Disorders | 1 | 2010 | 113 | 0.080 |
Why?
| Wnt Proteins | 1 | 2010 | 135 | 0.080 |
Why?
| Breeding | 1 | 2009 | 55 | 0.080 |
Why?
| Neovascularization, Pathologic | 1 | 2010 | 283 | 0.080 |
Why?
| Biomarkers, Tumor | 2 | 2012 | 1053 | 0.080 |
Why?
| RNA Polymerase II | 3 | 2017 | 285 | 0.080 |
Why?
| Estrogen Receptor alpha | 1 | 2009 | 121 | 0.080 |
Why?
| Sequence Analysis, DNA | 1 | 2011 | 728 | 0.070 |
Why?
| Sleep | 1 | 2013 | 632 | 0.070 |
Why?
| Macrophages, Alveolar | 1 | 2010 | 347 | 0.070 |
Why?
| Blood Platelets | 1 | 2010 | 351 | 0.070 |
Why?
| Data Collection | 1 | 2010 | 622 | 0.070 |
Why?
| Bacterial Proteins | 2 | 2003 | 739 | 0.070 |
Why?
| Pregnenolone Carbonitrile | 1 | 2006 | 2 | 0.070 |
Why?
| Models, Statistical | 1 | 2010 | 604 | 0.070 |
Why?
| Molecular Sequence Data | 4 | 2015 | 2791 | 0.070 |
Why?
| Receptors, Steroid | 1 | 2006 | 47 | 0.070 |
Why?
| Influenza, Human | 1 | 2012 | 546 | 0.070 |
Why?
| Up-Regulation | 2 | 2006 | 812 | 0.070 |
Why?
| Inflammation | 2 | 2014 | 2481 | 0.070 |
Why?
| Neoadjuvant Therapy | 1 | 2008 | 305 | 0.070 |
Why?
| Cell Nucleus | 1 | 2008 | 554 | 0.060 |
Why?
| RNA, Messenger | 6 | 2010 | 2557 | 0.060 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 2008 | 333 | 0.060 |
Why?
| Tumor Necrosis Factor alpha-Induced Protein 3 | 2 | 2016 | 11 | 0.060 |
Why?
| Mice, Inbred C57BL | 4 | 2021 | 4710 | 0.060 |
Why?
| Macrophages | 1 | 2012 | 1261 | 0.060 |
Why?
| Lung | 2 | 2010 | 3546 | 0.060 |
Why?
| Saccharomyces cerevisiae | 1 | 2008 | 477 | 0.060 |
Why?
| Protein Binding | 3 | 2016 | 1896 | 0.060 |
Why?
| Calcium | 1 | 2010 | 1103 | 0.060 |
Why?
| Signal Transduction | 6 | 2015 | 4521 | 0.060 |
Why?
| Alcoholism | 1 | 2010 | 714 | 0.060 |
Why?
| Transcription Factors | 2 | 2009 | 1528 | 0.060 |
Why?
| Mutagenesis | 3 | 2002 | 170 | 0.060 |
Why?
| Models, Biological | 3 | 2012 | 1630 | 0.060 |
Why?
| Female | 14 | 2021 | 59507 | 0.060 |
Why?
| Lipid Metabolism | 1 | 2006 | 446 | 0.060 |
Why?
| Cells, Cultured | 4 | 2017 | 3890 | 0.050 |
Why?
| Mitochondria | 1 | 2008 | 751 | 0.050 |
Why?
| Hemangioma, Cavernous | 1 | 2003 | 14 | 0.050 |
Why?
| Biological Specimen Banks | 1 | 2024 | 95 | 0.050 |
Why?
| Pregnancy, Animal | 1 | 2003 | 52 | 0.050 |
Why?
| Sequence Analysis, RNA | 2 | 2017 | 388 | 0.050 |
Why?
| Cell Membrane | 2 | 2006 | 679 | 0.050 |
Why?
| Tetracycline Resistance | 1 | 2002 | 5 | 0.050 |
Why?
| HLA-A Antigens | 1 | 2022 | 50 | 0.050 |
Why?
| Intracranial Arteriovenous Malformations | 1 | 2003 | 51 | 0.050 |
Why?
| Brain | 2 | 2013 | 2374 | 0.050 |
Why?
| Binding Sites | 4 | 2015 | 1176 | 0.050 |
Why?
| Liver | 2 | 2006 | 1631 | 0.050 |
Why?
| Statistics, Nonparametric | 1 | 2003 | 386 | 0.050 |
Why?
| Laser Capture Microdissection | 1 | 2021 | 23 | 0.050 |
Why?
| Histocompatibility Antigens | 1 | 2022 | 100 | 0.050 |
Why?
| Amino Acid Sequence | 3 | 2003 | 1988 | 0.050 |
Why?
| Mutation | 3 | 2021 | 3350 | 0.050 |
Why?
| Whole Genome Sequencing | 1 | 2021 | 94 | 0.050 |
Why?
| High-Throughput Nucleotide Sequencing | 2 | 2015 | 440 | 0.050 |
Why?
| Histocompatibility Antigens Class I | 1 | 2022 | 174 | 0.050 |
Why?
| Histocompatibility Antigens Class II | 1 | 2022 | 353 | 0.050 |
Why?
| Blotting, Western | 2 | 2016 | 1151 | 0.050 |
Why?
| Base Sequence | 2 | 2015 | 2118 | 0.050 |
Why?
| Chemokines | 2 | 2012 | 213 | 0.040 |
Why?
| STAT1 Transcription Factor | 2 | 2011 | 65 | 0.040 |
Why?
| Breast Neoplasms | 2 | 2009 | 1868 | 0.040 |
Why?
| Models, Genetic | 1 | 2003 | 565 | 0.040 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2016 | 1134 | 0.040 |
Why?
| Frameshift Mutation | 1 | 2019 | 27 | 0.040 |
Why?
| Disease Models, Animal | 2 | 2021 | 3542 | 0.040 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 797 | 0.040 |
Why?
| Polymerase Chain Reaction | 1 | 2021 | 994 | 0.040 |
Why?
| Apoptosis | 3 | 2014 | 2369 | 0.040 |
Why?
| Promoter Regions, Genetic | 2 | 2015 | 1133 | 0.040 |
Why?
| Pregnancy | 3 | 2006 | 5525 | 0.040 |
Why?
| Haplotypes | 1 | 2019 | 453 | 0.040 |
Why?
| Mutation, Missense | 1 | 2019 | 295 | 0.040 |
Why?
| Cross-Linking Reagents | 1 | 1998 | 181 | 0.040 |
Why?
| Jaw | 1 | 2017 | 15 | 0.040 |
Why?
| Hypertrophy | 1 | 2017 | 109 | 0.040 |
Why?
| Transduction, Genetic | 1 | 2017 | 113 | 0.040 |
Why?
| Nose | 1 | 2017 | 55 | 0.030 |
Why?
| Primary Cell Culture | 1 | 2017 | 149 | 0.030 |
Why?
| Tongue | 1 | 2017 | 67 | 0.030 |
Why?
| Genes, Reporter | 1 | 2017 | 257 | 0.030 |
Why?
| Hypoxia | 1 | 2003 | 957 | 0.030 |
Why?
| Adenoviridae | 1 | 2017 | 185 | 0.030 |
Why?
| Autoradiography | 1 | 1996 | 70 | 0.030 |
Why?
| Acetic Acid | 1 | 1996 | 16 | 0.030 |
Why?
| Indicators and Reagents | 1 | 1996 | 99 | 0.030 |
Why?
| Cell Proliferation | 2 | 2014 | 2196 | 0.030 |
Why?
| Acetates | 1 | 1996 | 95 | 0.030 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2015 | 73 | 0.030 |
Why?
| Brain Neoplasms | 1 | 2003 | 984 | 0.030 |
Why?
| Exons | 2 | 2010 | 303 | 0.030 |
Why?
| Transforming Growth Factor beta | 1 | 2017 | 449 | 0.030 |
Why?
| Recombinant Fusion Proteins | 1 | 2017 | 617 | 0.030 |
Why?
| Prognosis | 2 | 2012 | 3334 | 0.030 |
Why?
| RNA Interference | 1 | 2016 | 437 | 0.030 |
Why?
| Colorado | 1 | 2024 | 4086 | 0.030 |
Why?
| In Situ Hybridization | 1 | 2014 | 293 | 0.030 |
Why?
| Male | 8 | 2013 | 55579 | 0.030 |
Why?
| Protein Kinase Inhibitors | 2 | 2010 | 795 | 0.030 |
Why?
| Bronchi | 1 | 2015 | 232 | 0.030 |
Why?
| Cytokines | 2 | 2012 | 1843 | 0.030 |
Why?
| Enkephalins | 1 | 2013 | 13 | 0.030 |
Why?
| Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2013 | 9 | 0.030 |
Why?
| Education | 1 | 2013 | 95 | 0.030 |
Why?
| Cell Line, Tumor | 2 | 2010 | 2725 | 0.030 |
Why?
| Prealbumin | 1 | 2013 | 22 | 0.030 |
Why?
| Cartilage | 1 | 2014 | 182 | 0.030 |
Why?
| Middle Aged | 5 | 2012 | 26757 | 0.030 |
Why?
| Myosins | 1 | 2013 | 126 | 0.030 |
Why?
| RNA, Neoplasm | 1 | 2012 | 80 | 0.030 |
Why?
| Models, Molecular | 3 | 2003 | 1378 | 0.030 |
Why?
| Protein Precursors | 1 | 2013 | 119 | 0.030 |
Why?
| Mice, Inbred Strains | 1 | 2013 | 396 | 0.030 |
Why?
| Lectins, C-Type | 1 | 2012 | 61 | 0.020 |
Why?
| Transcriptional Activation | 1 | 2014 | 337 | 0.020 |
Why?
| Alleles | 1 | 2014 | 791 | 0.020 |
Why?
| Protein Structure, Secondary | 2 | 2003 | 325 | 0.020 |
Why?
| Exome | 1 | 2013 | 200 | 0.020 |
Why?
| Bone and Bones | 1 | 2014 | 278 | 0.020 |
Why?
| Immunophenotyping | 1 | 2012 | 275 | 0.020 |
Why?
| DNA Mutational Analysis | 2 | 2003 | 372 | 0.020 |
Why?
| Glucocorticoids | 1 | 2016 | 532 | 0.020 |
Why?
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2010 | 11 | 0.020 |
Why?
| Disease-Free Survival | 1 | 2012 | 623 | 0.020 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 316 | 0.020 |
Why?
| Genes, Neoplasm | 1 | 2010 | 20 | 0.020 |
Why?
| Tumor Suppressor Proteins | 1 | 2013 | 282 | 0.020 |
Why?
| Bronchoalveolar Lavage | 1 | 2010 | 84 | 0.020 |
Why?
| Fibroblasts | 1 | 2015 | 838 | 0.020 |
Why?
| Neoplasm Invasiveness | 1 | 2012 | 445 | 0.020 |
Why?
| Molecular Sequence Annotation | 1 | 2010 | 81 | 0.020 |
Why?
| Imatinib Mesylate | 1 | 2010 | 63 | 0.020 |
Why?
| Surface-Active Agents | 1 | 2011 | 79 | 0.020 |
Why?
| Dasatinib | 1 | 2010 | 46 | 0.020 |
Why?
| Caspases, Effector | 1 | 2010 | 2 | 0.020 |
Why?
| Phagocytosis | 1 | 2012 | 350 | 0.020 |
Why?
| Markov Chains | 1 | 2010 | 114 | 0.020 |
Why?
| Principal Component Analysis | 1 | 2010 | 176 | 0.020 |
Why?
| Amino Acid Motifs | 2 | 2000 | 198 | 0.020 |
Why?
| Thiazoles | 1 | 2010 | 110 | 0.020 |
Why?
| ras Proteins | 1 | 2010 | 138 | 0.020 |
Why?
| Polymorphism, Genetic | 1 | 2013 | 612 | 0.020 |
Why?
| Interferon Regulatory Factors | 1 | 2010 | 29 | 0.020 |
Why?
| Cyclosporine | 1 | 2010 | 161 | 0.020 |
Why?
| Rats, Sprague-Dawley | 2 | 2006 | 2209 | 0.020 |
Why?
| Demography | 1 | 2010 | 262 | 0.020 |
Why?
| Benzamides | 1 | 2010 | 169 | 0.020 |
Why?
| Genotype | 1 | 2014 | 1774 | 0.020 |
Why?
| Amino Acid Substitution | 2 | 2000 | 262 | 0.020 |
Why?
| Quality Control | 1 | 2009 | 144 | 0.020 |
Why?
| Inheritance Patterns | 1 | 2009 | 45 | 0.020 |
Why?
| Organ Specificity | 1 | 2009 | 268 | 0.020 |
Why?
| RNA Splicing | 1 | 2010 | 245 | 0.020 |
Why?
| Embryo, Mammalian | 1 | 2009 | 214 | 0.020 |
Why?
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2009 | 66 | 0.020 |
Why?
| Interferons | 1 | 2010 | 151 | 0.020 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 330 | 0.020 |
Why?
| Ethanol | 1 | 2013 | 548 | 0.020 |
Why?
| Blotting, Northern | 1 | 2008 | 193 | 0.020 |
Why?
| Tumor Cells, Cultured | 1 | 2010 | 854 | 0.020 |
Why?
| Kinetics | 1 | 2012 | 1550 | 0.020 |
Why?
| Neoplasm Staging | 1 | 2012 | 1176 | 0.020 |
Why?
| Neoplasm Metastasis | 1 | 2010 | 528 | 0.020 |
Why?
| Perilipin-1 | 1 | 2008 | 16 | 0.020 |
Why?
| Estrogen Receptor Modulators | 1 | 2008 | 17 | 0.020 |
Why?
| Cell Adhesion | 1 | 2009 | 430 | 0.020 |
Why?
| Adult | 4 | 2012 | 30548 | 0.020 |
Why?
| Bronchoalveolar Lavage Fluid | 1 | 2010 | 589 | 0.020 |
Why?
| RNA, Small Interfering | 1 | 2010 | 543 | 0.020 |
Why?
| Cell Communication | 1 | 2009 | 279 | 0.020 |
Why?
| Piperazines | 1 | 2010 | 311 | 0.020 |
Why?
| S100 Proteins | 1 | 2008 | 38 | 0.020 |
Why?
| Biomedical Research | 1 | 2013 | 585 | 0.020 |
Why?
| Curriculum | 1 | 2013 | 825 | 0.020 |
Why?
| Pyrimidines | 1 | 2010 | 378 | 0.020 |
Why?
| Data Interpretation, Statistical | 1 | 2009 | 322 | 0.020 |
Why?
| Tamoxifen | 1 | 2008 | 192 | 0.020 |
Why?
| Cell Cycle | 1 | 2009 | 543 | 0.020 |
Why?
| Phenotype | 1 | 2014 | 2812 | 0.020 |
Why?
| Flow Cytometry | 1 | 2010 | 1086 | 0.020 |
Why?
| Rats | 2 | 2006 | 4943 | 0.020 |
Why?
| Time Factors | 2 | 2009 | 6124 | 0.020 |
Why?
| Genome-Wide Association Study | 1 | 2012 | 1197 | 0.020 |
Why?
| Immunosuppressive Agents | 1 | 2010 | 647 | 0.020 |
Why?
| Chromatin | 1 | 2009 | 428 | 0.020 |
Why?
| Extracellular Matrix | 1 | 2009 | 435 | 0.020 |
Why?
| Retrospective Studies | 1 | 2022 | 12515 | 0.020 |
Why?
| Phosphoproteins | 1 | 2008 | 299 | 0.020 |
Why?
| Membrane Transport Proteins | 1 | 2006 | 138 | 0.020 |
Why?
| Quantitative Trait Loci | 1 | 2007 | 307 | 0.020 |
Why?
| Receptors, Estrogen | 1 | 2008 | 372 | 0.020 |
Why?
| Research Design | 1 | 2011 | 931 | 0.020 |
Why?
| Dietary Fats | 1 | 2006 | 287 | 0.010 |
Why?
| Carrier Proteins | 1 | 2008 | 696 | 0.010 |
Why?
| Cell Differentiation | 1 | 2011 | 1699 | 0.010 |
Why?
| Immunohistochemistry | 1 | 2008 | 1635 | 0.010 |
Why?
| Drug Resistance, Neoplasm | 1 | 2008 | 642 | 0.010 |
Why?
| Smoking | 1 | 2011 | 1384 | 0.010 |
Why?
| Sequence Analysis, Protein | 1 | 2003 | 28 | 0.010 |
Why?
| Milk Proteins | 1 | 2003 | 36 | 0.010 |
Why?
| Stromal Cells | 1 | 2003 | 96 | 0.010 |
Why?
| Osteopontin | 1 | 2003 | 32 | 0.010 |
Why?
| Disease Progression | 1 | 2010 | 2387 | 0.010 |
Why?
| Cohort Studies | 1 | 2012 | 4901 | 0.010 |
Why?
| Corpus Callosum | 1 | 2003 | 56 | 0.010 |
Why?
| Sulfhydryl Reagents | 1 | 2002 | 11 | 0.010 |
Why?
| Sialoglycoproteins | 1 | 2003 | 158 | 0.010 |
Why?
| Temporal Lobe | 1 | 2003 | 79 | 0.010 |
Why?
| Temporal Arteries | 1 | 2003 | 47 | 0.010 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 1361 | 0.010 |
Why?
| Reproducibility of Results | 1 | 2009 | 2763 | 0.010 |
Why?
| Frontal Lobe | 1 | 2003 | 140 | 0.010 |
Why?
| Mice, Transgenic | 1 | 2006 | 1951 | 0.010 |
Why?
| Plasmids | 1 | 2002 | 345 | 0.010 |
Why?
| Cysteine | 1 | 2002 | 171 | 0.010 |
Why?
| Structure-Activity Relationship | 1 | 2002 | 503 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 2009 | 2099 | 0.010 |
Why?
| Protein Structure, Tertiary | 1 | 2003 | 797 | 0.010 |
Why?
| Serine | 1 | 2000 | 126 | 0.010 |
Why?
| Conserved Sequence | 1 | 2000 | 218 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2011 | 6350 | 0.010 |
Why?
| Cyclic AMP | 1 | 2000 | 225 | 0.010 |
Why?
| Tyrosine | 1 | 2000 | 215 | 0.010 |
Why?
| Lipids | 1 | 2003 | 582 | 0.010 |
Why?
| Aged | 2 | 2011 | 19094 | 0.010 |
Why?
| Gene Deletion | 1 | 2000 | 356 | 0.010 |
Why?
| Escherichia coli | 1 | 2002 | 722 | 0.010 |
Why?
| Protein Conformation | 1 | 2000 | 811 | 0.010 |
Why?
| Pulmonary Artery | 1 | 2003 | 1012 | 0.010 |
Why?
| Antibodies | 1 | 1998 | 371 | 0.010 |
Why?
| Young Adult | 1 | 2010 | 10463 | 0.010 |
Why?
| Hypertension, Pulmonary | 1 | 2003 | 1728 | 0.010 |
Why?
| Adolescent | 1 | 2003 | 17808 | 0.000 |
Why?
| Child | 1 | 2003 | 18352 | 0.000 |
Why?
|
|
Phang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|